Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Immunotherapy of Glioblastoma Multiforme With Tumor-Sensitized, Ex Vivo Activated T Lymphocytes

NCT00003185 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00003185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Immunotherapy of Glioblastoma Multiforme With Tumor-Sensitized, Ex Vivo Activated T Lymphocytes
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1997
Completion date
July 31, 1998
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors